2 completed. 2 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 2 |
| Phase 1 | 1 | Completed 1 |
Follow Elif Oral: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study of Gemcabene in Adults With FPLD 300mg Gemcabene, 600mg Gemcabene - Familial Partial Lipodystrophy, Hypertriglyceridemia | Phase 1 / Phase 2 | Completed | Elif Oral | 5 | 2018-03-13 | 2020-08-17 |
| Recombinant Leptin Therapy for Treatment of Nonalcoholic Steatohepatitis (NASH) metreleptin - Fatty Liver Disease, Nonalcoholic | Phase 2 | Completed | Elif Oral | 9 | 2006-02-01 | 2017-11-24 |
Non-alcoholic Fatty Liver Disease (2) · Fatty Liver (1) · Hypertriglyceridemia (1) · Insulin Resistance (1) · Lipodystrophy, Familial Partial (1) · Obesity (1)
gemcabene (1) · metreleptin (1) · recombinant methionyl human leptin (1)
United States (2)
Elif A Oral, M.D. (1) · Elif A Oral, MD (1)
R03DK074488 (1)